Industry News

Bracco Imaging Acquires SurgVision

By Medimaging International staff writers
25 Oct 2017

Image: Bracco Imaging has acquired SurgVision (Photo courtesy of iStock).Bracco Imaging S.p.A. (Milan, Italy), a diagnostic imaging company, has acquired SurgVision ('t Harde, The Netherlands), which focuses on developing a real-time Fluorescence image guided surgery platform combining targeted imaging agent and a device for efficient tumors visualization during oncology surgical procedures.

Bracco Imaging S.p.A., a part of the Bracco Group, offers products and solutions for all key diagnostic imaging modalities, such as X- ray imaging (including computed tomography, interventional radiology, and cardiac catheterization), magnetic resonance imaging, contrast enhanced ultrasound, and nuclear medicine through radioactive tracers. It also offers various medical devices and advanced administration systems for contrast imaging products in the fields of radiology.

Fluorescence image guided surgery is an intra-operative optical technique to assist surgeons in distinguishing tumors from surrounding tissue, using a combined infrared camera and contrast agent approach. SurgVision's targeting solution is expected to provide significant improvements as compared to competing modalities and products, due to advanced features of its optical camera and sensitive targeting performance of its new imaging agent.

"With the acquisition of SurgVision, one of the most advanced companies in a very promising field, we intend to address a relevant, unmet medical need for oncology patients who have to undergo tumor removal surgery," said Fulvio Renoldi Bracco, Chief Executive Officer at Bracco Imaging. "SurgVision platform expands our imaging solutions for healthcare professionals in oncology and reinforces our long-lasting commitment to patient care."

"The investment in Surgvision provides Bracco Imaging with key competencies and technologies strategically adjacent to our core business," said Micol Fornaroli, Chief Strategy Officer at Bracco Imaging. "And at the same time, it will accelerate the development of the projects currently in scope of our Research and Development efforts."

"The acquisition of SurgVision by Bracco is a vote of confidence for the field of fluorescence image- guided surgery and for the achievements so far by the SurgVision team," said Ton van den Hoven, Chief Executive Officer at SurgVision. "The expertise and commitment from Bracco will allow SurgVision to continue developing a solution that delivers on the potential of important clinical benefits for patients."



E-mail Print
FaceBook Twitter Google+ Linked in

Bracco

Offers products, injectors and solutions portfolio for all diagnostic applications from constrast media to medical devices and advanced imaging agents injection systems
More info

More articles about Bracco

05 Apr 2017
Bracco Imaging Announces Strategic Investment in PHS Technologies Group
Bracco Imaging S.p.A., which develops, manufactures and markets diagnostic imaging agents and solutions, has announced a strategic investment in PHS Technologies Group, LLC, which is a division of PACSHealth, LLC, a medical software development company.
Read More

Additional news

26 Mar 2019
AI Predicts How NSCLC Patients Will Respond to Chemotherapy
Researchers may soon be able to predict which lung cancer patients will respond to chemotherapy by using data from computed tomography (CT) images.
Read More
26 Mar 2019
Global Urinalysis Market Valued at USD 2 Billion by 2022
The global urinalysis market is expected to grow at a CAGR of 7.5% from 2018 to 2022 to reach a value of USD 2.14 billion by 2022, driven by a large base of the target population and increasing demand for urinalysis due to unmet clinical needs in the under-developed regions globally.
Read More
26 Mar 2019
Global ECG Devices Market to Reach USD 6.7 Billion by 2026
The global ECG devices market was valued at USD 3.95 billion in 2017 and is projected to grow at a CAGR of 6.2% from 2018 to 2026 to reach USD 6.79 billion by 2026.
Read More
21 Mar 2019
Baxter and bioMérieux in Alliance to Develop Acute Kidney Injury Diagnostics
Baxter International Inc. and bioMérieux announced an agreement to develop future biomarkers with the goal to rapidly identify and inform treatment of acute kidney injury (AKI).
Read More
19 Mar 2019
Advantech Launches All-in-One Computer for Healthcare Applications
Advantech, a provider of medical computing systems, has launched its POC-L series of non-medical-grade point-of-care touch computers comprising two models differentiated according to their display size – POC-W213L (21.5 inches) and POC-W243L (23.8 inches).
Read More
19 Mar 2019
AI Algorithm Identifies Lung Tumors Faster Than Other Methods
Computing scientists at the University of Alberta have developed a neural network that outperforms other state-of-the-art methods of identifying lung tumors from MRI scans—creating the potential to help reduce damage to healthy tissue during radiation treatment.
Read More
19 Mar 2019
Machine Learning Method Can Help Women Avoid Unnecessary Breast Surgery
A team of researchers from the Geisel School of Medicine at Dartmouth has developed a machine learning method to predict atypical ductal hyperplasia (ADH) upgrade to cancer.
Read More
19 Mar 2019
First AI-Based Tool for Pulmonary Embolism Receives CE Certification
Aidoc, a provider of artificial intelligence (AI) solutions for radiologists, has announced the commercial release of its CE-marked product for the identification and triage of pulmonary embolism (PE) in CT pulmonary angiograms.
Read More
19 Mar 2019
World’s First AI-Based Algorithms for ED Receive CE Certification
Zebra Medical Vision has received two new CE marked registrations for its deep learning algorithms that help radiologists and Emergency Room (ER) staff to prioritize acute conditions for the first time in both CT scans and X-rays and reduce reports turnaround time (RTAT).
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions